Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ARVN · against 596 other Healthcare companies listed in US-listed
Ranked #218 of 597 · scores higher than 64% of peers · safety percentile 67
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)35 peers with a safety percentile of 60–69, including ARVN · Click a bar to see the companies
A mix: stronger debt / equity and current ratio, but weaker beta than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | ARVN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 523 reported | 0.01× | 0.23× | 85% | 33% | |
| BetaLower is better · 556 reported | 1.81 | 0.95 | 15% | 33% | |
| Current ratioHigher is better · 600 reported | 7.91× | 3.91× | 71% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 186M USD | 100 | 52 | |
| 4 | 1.5B USD | 100 | 44 | |
| 5 | 1.2B USD | 100 | 40 | |
| 214 | 54.9B USD | 68 | 59 | |
| 215 | 2.0B USD |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 67 |
| 24 |
| 216 | 10.7B USD | 67 | 78 |
| 217 | 4.0B USD | 67 | 30 |
| 218 | 457M USD | 67 | 58 |
| 219 | 9.0B USD | 67 | 33 |
| 220 | 1.5B USD | 66 | 59 |
| 221 | 275M USD | 66 | 46 |
| 222 | 1.3B USD | 65 | 30 |